Original language | English |
---|---|
Pages (from-to) | 313-325 |
Journal | Journal of Inherited Metabolic Disease |
Volume | 46 |
Issue number | 2 |
DOIs | |
Publication status | Published - 18 Jan 2023 |
Externally published | Yes |
Funding
The authors are grateful to all patients and their parents, all involved clinicians and laboratory specialists for their contributions to the study. Figures are made by Biorender. Glycomic studies were supported by ZonMw Medium Investment Grant 40‐00506‐98‐9001 and EUROGLYCAN‐omics (ERARE18‐117) by ZonMw (90030376501), under the frame of E‐Rare‐3, the ERA‐Net for Research on Rare Diseases. The research conducted at the Murdoch Children's Research Institute was supported by the State Government of Victoria's Operational Infrastructure Support Program. The Chair in Genomic Medicine awarded to JC is generously supported by The Royal Children's Hospital Foundation. Katrin Õunap and Mari‐Anne Vals are supported by Eesti Teadusagentuur grant PRG471. The research conduction at Amsterdam UMC is supported by Stichting Metakids, NL. Several author(s) (DJL, CvK, SBW) of this publication are (affiliated) members of the European Reference Network for Rare Hereditary Metabolic Disorders (MetabERN) ‐ Project ID No. 739543. The funding organizations had no role in the design or conduct of this research. The authors are grateful to all patients and their parents, all involved clinicians and laboratory specialists for their contributions to the study. Figures are made by Biorender. Glycomic studies were supported by ZonMw Medium Investment Grant 40-00506-98-9001 and EUROGLYCAN-omics (ERARE18-117) by ZonMw (90030376501), under the frame of E-Rare-3, the ERA-Net for Research on Rare Diseases. The research conducted at the Murdoch Children's Research Institute was supported by the State Government of Victoria's Operational Infrastructure Support Program. The Chair in Genomic Medicine awarded to JC is generously supported by The Royal Children's Hospital Foundation. Katrin Õunap and Mari-Anne Vals are supported by Eesti Teadusagentuur grant PRG471. The research conduction at Amsterdam UMC is supported by Stichting Metakids, NL. Several author(s) (DJL, CvK, SBW) of this publication are (affiliated) members of the European Reference Network for Rare Hereditary Metabolic Disorders (MetabERN) - Project ID No. 739543. The funding organizations had no role in the design or conduct of this research. E‐Rare, Grant/Award Number: 90030376501; Estonian Research Council, Grant/Award Number: PRG471; ZonMW Medium Investment Grant, Grant/Award Number: 40‐00506‐98‐9001; State Government of Victoria's Operational Infrastructure Support Program; The Royal Children's Hospital Foundation; Stichting Metakids Funding information
Funders | Funder number |
---|---|
ERA‐Net for Research on Rare Diseases | |
European Reference Network for Rare Hereditary Metabolic Disorders | 739543 |
ZonMw Medium Investment | |
Royal Children's Hospital Foundation | |
Stichting Metakids | |
ZonMw | 40‐00506‐98‐9001, ERARE18‐117, 90030376501 |
Eesti Teadusagentuur | PRG471 |
State Government of Victoria |